{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:14:59Z","timestamp":1794572099704,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016263","name":"Penn Mental Health AIDS Research Center","doi-asserted-by":"publisher","award":["P30 MH 097488"],"award-info":[{"award-number":["P30 MH 097488"]}],"id":[{"id":"10.13039\/100016263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The harms of opioid use disorder (OUD) and HIV infection disproportionately impact marginalized populations, especially people experiencing homelessness and people who inject drugs (PWID). Mobile OUD service delivery models are emerging to increase access and reduce barriers to OUD care. While there is growing interest in these models, there is limited research about the services they provide, how they operate, and what barriers they face. We characterize the capacity, barriers, and sustainment of mobile OUD care services in a large city with a high incidence of OUD and HIV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From May to August 2022, we conducted semi-structured\u202finterviews with leadership from\u202fall seven mobile OUD care units (MOCU) providing a medication for OUD or other substance use disorder services in Philadelphia. We surveyed leaders about their unit\u2019s services, staffing, operating location, funding sources, and linkages to care. Leaders were asked to describe their\u202fclinical approach, treatment process, and the barriers and facilitators to their operations. Interview recordings were coded using rapid qualitative analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MOCUs are run by small, multidisciplinary teams, typically composed of a clinician, one or two case managers, and a peer recovery specialist or outreach worker. MOCUs provide a range of services, including medications for OUD, wound care, medical services, case management, and screening for infectious diseases. No units provide methadone, but all units provide naloxone, six write prescriptions for buprenorphine, and one unit dispenses buprenorphine. The most frequently reported barriers include practical challenges of working on a MOCU (e.g. lack of space, safety), lack of community support, and patients with substantial medical and psychosocial needs. Interviewees reported concerns about funding and specifically as it relates to providing their staff with adequate pay. The most frequently reported facilitators include positive relationships with the community, collaboration with other entities (e.g. local nonprofits, the police department, universities), and having non-clinical staff (e.g. outreach workers, peer recovery specialists) on the unit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MOCUs provide life-saving services and engage marginalized individuals with OUD. These findings highlight the challenges and complexities of caring for PWID and demonstrate a need to strengthen collaborations between MOCU providers and the treatment system. Policymakers should consider programmatic funding for permanent mobile OUD care services.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-023-00427-5","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T19:02:01Z","timestamp":1701284521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Mobile service delivery in response to the opioid epidemic in Philadelphia"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6453-6715","authenticated-orcid":false,"given":"Rebecca E.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna P.","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Cardamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Drob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Mandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Lowenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"427_CR1","unstructured":"Ahman F, Cisewski J, Rossen L, Sutton P. National Center for Health Statistics. 2022. Provisional Drug Overdose Data. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm. Accessed 11 Oct 2022"},{"key":"427_CR2","unstructured":"CDC WONDER. https:\/\/wonder.cdc.gov\/. Accessed 2 Feb 2023"},{"key":"427_CR3","unstructured":"Philadelphia 2022: The State of the City. 2022. p. 6. (The PEW Charitiable Trusts). https:\/\/www.pewtrusts.org\/-\/media\/assets\/2022\/04\/philadelphia-2022-the-state-of-the-city.pdf. Accessed 11 Oct 2022"},{"key":"427_CR4","unstructured":"Higgins D, Johnson J, Andrews A, Puleo M, Teixeira da Silva D, Kurzer-Yashin D, et al. Unintentional drug overdose fatalities in Philadelphia, 2021. Philadelphia Department of Public Health; 2022. p. 7."},{"issue":"1","key":"427_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12889-022-12604-3","volume":"22","author":"LM Randall","year":"2022","unstructured":"Randall LM, Dasgupta S, Day J, DeMaria A, Musolino J, John B, et al. An outbreak of HIV infection among people who inject drugs in northeastern Massachusetts: findings and lessons learned from a medical record review. BMC Public Health. 2022;22(1):257.","journal-title":"BMC Public Health"},{"issue":"2","key":"427_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","volume":"108","author":"JE Zibbell","year":"2018","unstructured":"Zibbell JE, Asher AK, Patel RC, Kupronis B, Iqbal K, Ward JW, et al. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175\u201381.","journal-title":"Am J Public Health"},{"key":"427_CR7","unstructured":"A Community Plan to End the HIV Epidemic in Philadelphia. Philadelphia, PA: Department of Public Health; 2020. https:\/\/www.phila.gov\/media\/20201201165516\/Ending-the-HIV-Epidemic-in-Philadelphia-A-Community-Plan.pdf"},{"issue":"1","key":"427_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","volume":"110","author":"C Alpren","year":"2020","unstructured":"Alpren C, Dawson EL, John B, Cranston K, Panneer N, Fukuda HD, et al. Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs\u2014Massachusetts, 2015\u20132018. Am J Public Health. 2020;110(1):37\u201344.","journal-title":"Am J Public Health"},{"key":"427_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.annepidem.2019.02.012","volume":"34","author":"H Bradley","year":"2019","unstructured":"Bradley H, Hogan V, Agnew-Brune C, Armstrong J, Broussard D, Buchacz K, et al. Increased HIV diagnoses in West Virginia counties highly vulnerable to rapid HIV dissemination through injection drug use: a cautionary tale. Ann Epidemiol. 2019;34:12\u20137.","journal-title":"Ann Epidemiol"},{"key":"427_CR10","doi-asserted-by":"crossref","unstructured":"Golden MR. Outbreak of Human Immunodeficiency Virus Infection Among Heterosexual Persons Who Are Living Homeless and Inject Drugs\u2014Seattle, Washington, 2018. MMWR Morb Mortal Wkly Rep. 2019; 68. https:\/\/www.cdc.gov\/mmwr\/volumes\/68\/wr\/mm6815a2.htm. Accessed 2 Feb 2023","DOI":"10.15585\/mmwr.mm6815a2"},{"issue":"1","key":"427_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13011-022-00439-5","volume":"17","author":"N Farhadian","year":"2022","unstructured":"Farhadian N, Karami Matin B, Farnia V, Zamanian MH, Najafi F, Farhadian M. The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis. Subst Abuse Treat Prev Policy. 2022;17(1):11.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"8","key":"427_CR12","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s11606-020-05779-1","volume":"35","author":"DR Fine","year":"2020","unstructured":"Fine DR, Yu L, Triant VA, Baggett TP, Metlay JP. Baseline factors associated with mortality in patients who engaged in buprenorphine treatment for opioid use disorder: a cohort study. J Gen Intern Med. 2020;35(8):2375\u201382.","journal-title":"J Gen Intern Med"},{"key":"427_CR13","unstructured":"Raval-Nelson P, Brady KA. HIV Surveillance Report. Philadelphia, PA: City of Philadelphia; 2022. (Philadelphia Department of Public Health AIDS Activities Coordinating Office)."},{"issue":"2","key":"427_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/07370016.2016.1159439","volume":"33","author":"J Zur","year":"2016","unstructured":"Zur J, Linton S, Mead H. Medical respite and linkages to outpatient health care providers among individuals experiencing homelessness. J Community Health Nurs. 2016;33(2):81\u20139.","journal-title":"J Community Health Nurs"},{"issue":"1","key":"427_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12954-020-00399-8","volume":"17","author":"B Muncan","year":"2020","unstructured":"Muncan B, Walters SM, Ezell J, Ompad DC. \u201cThey look at us like junkies\u201d: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):53.","journal-title":"Harm Reduct J"},{"key":"427_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108377","volume":"129","author":"RE Stewart","year":"2021","unstructured":"Stewart RE, Shen L, Kwon N, Vigderman J, Kramer S, Mandell DS, et al. Transporting to treatment: evaluating the effectiveness of a mobile engagement unit. J Subst Abuse Treat. 2021;129: 108377.","journal-title":"J Subst Abuse Treat"},{"issue":"244","key":"427_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109782","volume":"1","author":"LD Williams","year":"2023","unstructured":"Williams LD, Lee E, Kristensen K, Mackesy-Amiti ME, Boodram B. Community-, network-, and individual-level predictors of uptake of medication for opioid use disorder among young people who inject drugs and their networks: a multilevel analysis. Drug Alcohol Depend. 2023;1(244): 109782.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"427_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/08897077.2019.1671942","volume":"41","author":"R Simon","year":"2020","unstructured":"Simon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: a qualitative study. Subst Abuse. 2020;41(4):519\u201325.","journal-title":"Subst Abuse"},{"key":"427_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108752","volume":"138","author":"N Swartz","year":"2022","unstructured":"Swartz N, Adnan T, Per\u00e9a F, Baggett TP, Chatterjee A. \u201cSick and tired of being sick and tired\u201d: exploring initiation of medications for opioid use disorder among people experiencing homelessness. J Subst Abuse Treat. 2022;138: 108752.","journal-title":"J Subst Abuse Treat"},{"key":"427_CR20","unstructured":"Policies should promote access to buprenorphine for opioid use disorder. The pew charitable trusts; 2021 (Substance Use Prevention and Treatment). https:\/\/pew.org\/3hIuu9e. Accessed 6 Mar 2023"},{"issue":"1","key":"427_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13011-022-00483-1","volume":"17","author":"BH Lambdin","year":"2022","unstructured":"Lambdin BH, Kan D, Kral AH. Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs. Subst Abuse Treat Prev Policy. 2022;17(1):51.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"427_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209054","volume":"150","author":"SE Messmer","year":"2023","unstructured":"Messmer SE, Elmes AT, Jimenez AD, Murphy AL, Guzman M, Watson DP, et al. Outcomes of a mobile medical unit for low-threshold buprenorphine access targeting opioid overdose hot spots in Chicago. J Subst Use Addict Treat. 2023;150: 209054.","journal-title":"J Subst Use Addict Treat."},{"issue":"1","key":"427_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12954-023-00778-x","volume":"20","author":"R Gadomski","year":"2023","unstructured":"Gadomski R, Bhatt S, Gross J, Dixon JA, Fiuty P, Shapiro M, et al. Descriptive study: the novel \u201cfull spectrum people-with-opioid-use-disorder care model.\u201d Harm Reduct J. 2023;20(1):47.","journal-title":"Harm Reduct J"},{"issue":"3","key":"427_CR24","volume":"14","author":"F Breve","year":"2022","unstructured":"Breve F, Batastini L, LeQuang JAK, Marchando G. Mobile narcotic treatment programs: on the road again? Cureus. 2022;14(3): e23221.","journal-title":"Cureus"},{"key":"427_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108483","volume":"129","author":"B Chan","year":"2021","unstructured":"Chan B, Hoffman KA, Bougatsos C, Grusing S, Chou R, McCarty D. Mobile methadone medication units: a brief history, scoping review and research opportunity. J Subst Abuse Treat. 2021;129: 108483.","journal-title":"J Subst Abuse Treat"},{"key":"427_CR26","unstructured":"Coderre T, Bullock J, Johnson Byrd DC. 2021 Report to Congress on the State Opioid Response Grants (SOR). Substance Abuse and Mental Health Services Administration; 2021."},{"key":"427_CR27","unstructured":"CODAC Behavioral Healthcare. 2022. CODAC Announces Mobile Medical Unit Able to Dispense Methadone as Part of Full MAT. https:\/\/codacinc.org\/news-articles\/codac-announces-mobile-medical-unit\/. Accessed 23 Feb 2023"},{"key":"427_CR28","unstructured":"State Opioid Response Grant: mobile health units delivering MAT treatment year two evaluation report. colorado department of human services, office of behavioral health.: The Evaluation Center, University of Colorado Denver; 2020."},{"key":"427_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108553","volume":"133","author":"A Rosecrans","year":"2022","unstructured":"Rosecrans A, Harris R, Saxton RE, Cotterell M, Zoltick M, Willman C, et al. Mobile low-threshold buprenorphine integrated with infectious disease services. J Subst Abuse Treat. 2022;133: 108553.","journal-title":"J Subst Abuse Treat"},{"key":"427_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108717","volume":"224","author":"MF McLaughlin","year":"2021","unstructured":"McLaughlin MF, Li R, Carrero ND, Bain PA, Chatterjee A. Opioid use disorder treatment for people experiencing homelessness: a scoping review. Drug Alcohol Depend. 2021;224: 108717.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"427_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/07853890.2021.2022188","volume":"54","author":"SM Grieb","year":"2022","unstructured":"Grieb SM, Harris R, Rosecrans A, Zook K, Sherman SG, Greenbaum A, et al. Awareness, perception and utilization of a mobile health clinic by people who use drugs. Ann Med. 2022;54(1):138\u201349.","journal-title":"Ann Med"},{"issue":"6","key":"427_CR32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/ajad.13055","volume":"29","author":"T Iheanacho","year":"2020","unstructured":"Iheanacho T, Payne K, Tsai J. Mobile, community-based buprenorphine treatment for veterans experiencing homelessness with opioid use disorder: a pilot, feasibility study. Am J Addict. 2020;29(6):485\u201391.","journal-title":"Am J Addict"},{"issue":"5","key":"427_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1370\/afm.2565","volume":"18","author":"DT O\u2019Gurek","year":"2020","unstructured":"O\u2019Gurek DT, Strand N, Gibbs J, Hoover-Hankerson B, Jegede VO. Begin the turn: a mobile recovery program for a targeted urban population. Ann Fam Med. 2020;18(5):465\u2013465.","journal-title":"Ann Fam Med"},{"issue":"8","key":"427_CR34","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fpubh.2020.00501","volume":"25","author":"C Regis","year":"2020","unstructured":"Regis C, Gaeta JM, Mackin S, Baggett TP, Quinlan J, Taveras EM. Community care in reach: mobilizing harm reduction and addiction treatment services for vulnerable populations. Front Public Health. 2020;25(8):501.","journal-title":"Front Public Health"},{"key":"427_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108149","volume":"120","author":"K Wenzel","year":"2021","unstructured":"Wenzel K, Fishman M. Mobile van delivery of extended-release buprenorphine and extended-release naltrexone for youth with OUD: An adaptation to the COVID-19 emergency. J Subst Abuse Treat. 2021;120: 108149.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"427_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0376-8716(96)01273-2","volume":"42","author":"L Greenfield","year":"1996","unstructured":"Greenfield L, Brady JV, Besteman KJ, De Smet A. Patient retention in mobile and fixed-site methadone maintenance treatment. Drug Alcohol Depend. 1996;42(2):125\u201331.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"427_CR37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jsat.2013.11.002","volume":"46","author":"G Hall","year":"2014","unstructured":"Hall G, Neighbors CJ, Iheoma J, Dauber S, Adams M, Culleton R, et al. Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals. J Subst Abuse Treat. 2014;46(4):511\u20135.","journal-title":"J Subst Abuse Treat"},{"key":"427_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108753","volume":"138","author":"M Gaeta Gazzola","year":"2022","unstructured":"Gaeta Gazzola M, Carmichael ID, Madden LM, Dasgupta N, Beitel M, Zheng X, et al. A cohort study examining the relationship among housing status, patient characteristics, and retention among individuals enrolled in low-barrier-to-treatment-access methadone maintenance treatment. J Subst Abuse Treat. 2022;138: 108753.","journal-title":"J Subst Abuse Treat"},{"key":"427_CR39","unstructured":"HIV Prevention Trials Network Launches HPTN 094 (INTEGRA) Study | The HIV Prevention Trials Network. 2021. https:\/\/www.hptn.org\/news-and-events\/press-releases\/hiv-prevention-trials-network-launches-hptn-094-integra-study. Accessed 23 Feb 2023"},{"key":"427_CR40","unstructured":"Murphy K, Levine R, Tennis G. Physicians General\u2019s Standing Order Prescription for Naloxone for Eligible Persons under Act 139 of 2014. 2015."},{"key":"427_CR41","unstructured":"City of Philadelphia. 2023. Harm reduction | Programs and initiatives. https:\/\/www.phila.gov\/programs\/substance-use-prevention-and-harm-reduction\/harm-reduction\/. Accessed 24 Oct 2023"},{"key":"427_CR42","unstructured":"City of Philadelphia. 2023. Substance Use Prevention and Harm Reduction | Programs and initiatives. https:\/\/www.phila.gov\/programs\/substance-use-prevention-and-harm-reduction\/. Accessed 24 Oct 2023"},{"key":"427_CR43","unstructured":"Syringe Services Program | Prevention Point. https:\/\/ppponline.org\/node\/231\/syringe-services-program. Accessed 24 Oct 2023"},{"issue":"3","key":"427_CR44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.annemergmed.2021.10.012","volume":"79","author":"M Lowenstein","year":"2022","unstructured":"Lowenstein M, Perrone J, Xiong RA, Snider CK, O\u2019Donnell N, Hermann D, et al. Sustained implementation of a multicomponent strategy to increase emergency department-initiated interventions for opioid use disorder. Ann Emerg Med. 2022;79(3):237\u201348.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"427_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12954-021-00572-7","volume":"18","author":"SV Aronowitz","year":"2021","unstructured":"Aronowitz SV, Engel-Rebitzer E, Dolan A, Oyekanmi K, Mandell D, Meisel Z, et al. Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives. Harm Reduct J. 2021;18(1):119.","journal-title":"Harm Reduct J"},{"key":"427_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100055","volume":"3","author":"KM Ward","year":"2022","unstructured":"Ward KM, Scheim A, Wang J, Cocchiaro B, Singley K, Roth AM. Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program. Drug Alcohol Depend Rep. 2022;3: 100055.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"1","key":"427_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated consolidated framework for implementation research based on user feedback. Implement Sci. 2022;17(1):75.","journal-title":"Implement Sci"},{"key":"427_CR48","unstructured":"Hamilton A. Rapid Qualitative Analysis: Updates\/Developments. 2020. https:\/\/www.hsrd.research.va.gov\/for_researchers\/cyber_seminars\/archives\/video_archive.cfm?SessionID=3846. Accessed 21 Dec 2022"},{"key":"427_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.112516","volume":"280","author":"AB Hamilton","year":"2019","unstructured":"Hamilton AB, Finley EP. Qualitative methods in implementation research: an introduction. Psychiatry Res. 2019;280: 112516.","journal-title":"Psychiatry Res"},{"issue":"10","key":"427_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019993","volume":"8","author":"B Taylor","year":"2018","unstructured":"Taylor B, Henshall C, Kenyon S, Litchfield I, Greenfield S. Can rapid approaches to qualitative analysis deliver timely, valid findings to clinical leaders? A mixed methods study comparing rapid and thematic analysis. BMJ Open. 2018;8(10): e019993.","journal-title":"BMJ Open"},{"key":"427_CR51","unstructured":"Liang S, Fu Y. Otter.ai [Computer software] 2016. https:\/\/otter.ai\/"},{"issue":"6","key":"427_CR52","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care J Int Soc Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care J Int Soc Qual Health Care"},{"issue":"10","key":"427_CR53","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1177\/1049732320921835","volume":"30","author":"C Vindrola-Padros","year":"2020","unstructured":"Vindrola-Padros C, Johnson GA. Rapid techniques in qualitative research: a critical review of the literature. Qual Health Res. 2020;30(10):1596\u2013604.","journal-title":"Qual Health Res"},{"issue":"6","key":"427_CR54","first-page":"2045","volume":"26","author":"R Maietta","year":"2021","unstructured":"Maietta R, Mihas P, Swartout K, Petruzzelli J, Hamilton A. Sort and sift, think and shift: let the data be your guide an applied approach to working with, learning from, and privileging qualitative data. Qual Rep. 2021;26(6):2045\u201360.","journal-title":"Qual Rep"},{"key":"427_CR55","unstructured":"Mobile Treatment for Opioid Use Disorder: Examples From the Field\u2014Part 1. Bureau of Justice Assistance; 2020. (Comprehensive Opioid, Stimulant, and Substance Use Program)."},{"key":"427_CR56","unstructured":"Mobile Treatment for Opioid Use Disorder: Examples From the Field\u2014Part II. Bureau of Justice Assistance; 2021 p. 5. (Comprehensive Opioid, Stimulant, and Substance Use Program). Report No.: 302607. https:\/\/bja.ojp.gov\/library\/publications\/mobile-treatment-opioid-use-disorder-examples-field-part-ii. Accessed 12 Apr 2023"},{"key":"427_CR57","unstructured":"Mobile Treatment for Opioid Use Disorder: Examples From the Field\u2014Part III. Bureau of Justice Assistance; 2022. (Comprehensive Opioid, Stimulant, and Substance Use Program)."},{"issue":"7","key":"427_CR58","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1176\/appi.ps.202100276","volume":"73","author":"BS Last","year":"2022","unstructured":"Last BS, Schriger SH, Becker-Haimes EM, Fernandez-Marcote S, Dallard N, Jones B, et al. Economic precarity, financial strain, and job-related stress among Philadelphia\u2019s public mental health clinicians. Psychiatr Serv. 2022;73(7):774\u201386.","journal-title":"Psychiatr Serv"},{"issue":"15","key":"427_CR59","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMp2210121","volume":"387","author":"R Gupta","year":"2022","unstructured":"Gupta R, Levine RL, Cepeda JA, Holtgrave DR. Transforming management of opioid use disorder with universal treatment. N Engl J Med. 2022;387(15):1341\u20134.","journal-title":"N Engl J Med"},{"issue":"2","key":"427_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/ADM.0000000000000555","volume":"14","author":"A Jakubowski","year":"2020","unstructured":"Jakubowski A, Fox A. Defining Low-threshold Buprenorphine treatment. J Addict Med. 2020;14(2):95\u20138.","journal-title":"J Addict Med"},{"key":"427_CR61","unstructured":"Drug Enforcement Administration D of J. Registration Requirements for Narcotic Treatment Programs With Mobile Components. 2021."},{"key":"427_CR62","unstructured":"DiDomenico E. Licensing Alert 02\u201322. Pennsylvania Department of Drug and Alcohol Programs; 2022."},{"key":"427_CR63","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.apnu.2023.09.001","volume":"46","author":"SL Cody","year":"2023","unstructured":"Cody SL, Newman S, Bui C, Sharp-Marbury R, Scott L. Substance use and opioid-related stigma among Black communities in the rural South. Arch Psychiatr Nurs. 2023;46:127\u201332.","journal-title":"Arch Psychiatr Nurs"},{"issue":"4","key":"427_CR64","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/jrh.12737","volume":"39","author":"D Button","year":"2023","unstructured":"Button D, Levander XA, Cook RR, Miller WC, Salisbury-Afshar EM, Tsui JI, et al. Substance use disorder treatment and technology access among people who use drugs in rural areas of the United States: a cross-sectional survey. J Rural Health. 2023;39(4):772\u20139.","journal-title":"J Rural Health"},{"key":"427_CR65","doi-asserted-by":"publisher","unstructured":"The New Mobile Methadone Rules And What They Mean For Treatment Access. 2021. http:\/\/www.healthaffairs.org\/do\/https:\/\/doi.org\/10.1377\/forefront.20210727.942168\/full\/. Accessed 24 Oct 2023","DOI":"10.1377\/forefront.20210727.942168\/full"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00427-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-023-00427-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00427-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T20:02:42Z","timestamp":1701288162000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-023-00427-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1186\/s13722-023-00427-5","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"assertion":[{"value":"2 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Pennsylvania Review Board approved all procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}